Department of Emergency Medicine, University of Melbourne, Australia.
Department of Anesthesia.
Pediatr Infect Dis J. 2019 Feb;38(2):e20-e25. doi: 10.1097/INF.0000000000002070.
Outpatient parenteral antimicrobial therapy offers the option of treating children requiring intravenous antibiotics for acute urinary tract infection (UTI)/pyelonephritis at home. We aimed to determine the outcomes of treating patients with UTI/pyelonephritis using outpatient parenteral antimicrobial therapy directly from the emergency department (ED) without admission to hospital.
This was a retrospective study (August 2012-July 2016) of children with UTI/pyelonephritis treated with parenteral antibiotics via a peripheral cannula directly from ED to home under a hospital-in-the home (HITH) program. Data collection included demographics, clinical features, length of stay, complications, and readmissions to hospital.
There were 62 patient episodes of UTI/pyelonephritis transferred directly from ED to HITH. Fifty-eight (94%) had systemic features including fever, vomiting and/or tachycardia. Eighteen (29%) patients had an underlying condition. Nine (15%) received intravenous fluids and 8 (13%) antiemetics in ED. The outpatient parenteral antimicrobial therapy course was successfully completed in 56 (90%) patients. Of 6 (10%) patients who were readmitted, 2 were discharged within 24 hours, and none were severely unwell. Two (3%) had a blocked cannula, with no antibiotic complications. HITH patients were treated for a combined total of 142 days at home resulting in a cost saving of Australian dollar 108,914 (US dollar 82,775). However, only 8% of children deemed to require a course of intravenous antibiotics were transferred directly home from ED. Compared with patients concurrently admitted to hospital, fewer on HITH were less than 1 year of age (13% vs. 33%; odds ratio: 0.3; P < 0.01).
Selected patients presenting to ED with UTI/pyelonephritis may be treated directly via HITH, including some with underlying conditions and/or systemic features.
门诊患者接受静脉用抗生素治疗,为急性下尿路感染(UTI)/肾盂肾炎患儿提供了在家中接受静脉抗生素治疗的选择。我们旨在确定直接从急诊科(ED)开始接受门诊患者接受静脉用抗生素治疗(UTI)/肾盂肾炎的患者的结局,而无需住院。
这是一项回顾性研究(2012 年 8 月至 2016 年 7 月),纳入了通过医院到家(HITH)计划,通过外周套管直接从 ED 转至家中接受静脉用抗生素治疗的 UTI/肾盂肾炎患儿。数据收集包括人口统计学特征、临床特征、住院时间、并发症和再入院情况。
共有 62 例 UTI/肾盂肾炎患者直接从 ED 转至 HITH,其中 58 例(94%)存在全身症状,包括发热、呕吐和/或心动过速。18 例(29%)患者存在基础疾病。9 例(15%)患者在 ED 中接受了静脉补液,8 例(13%)患者接受了止吐药治疗。56 例(90%)患者成功完成了门诊静脉用抗生素治疗。在 6 例(10%)再入院患者中,2 例在 24 小时内出院,无严重不适。2 例(3%)出现套管堵塞,但无抗生素相关并发症。HITH 患者在家中总共接受了 142 天的治疗,节省费用 108914 澳元(82775 美元)。然而,仅有 8%的患儿被认为需要静脉用抗生素治疗,因此从 ED 直接转回家中。与同时住院的患者相比,HITH 患者中年龄小于 1 岁的患儿较少(13%比 33%;比值比:0.3;P<0.01)。
选择合适的 ED 就诊的 UTI/肾盂肾炎患儿可直接通过 HITH 进行治疗,包括一些有基础疾病和/或全身症状的患儿。